Work

Abstract B196: Entinostat: A novel class 1 isoform selective histone deacetylase inhibitor (HDACi) with unique pharmacological properties

Year: 2009

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-09-b196

Authors: Peter Ordentlich, Gloria Lee, Lori Kunkel, Edward Sausville

Institutions: Syndax Pharmaceuticals (United States), University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2012579821

Cites:

Cited by:

Related to: 10